The nation of Zimbabwe has declined a significant American health deal worth 367 million US dollars (272 million pounds) over five years over the United States' insistence on sensitive biological samples.
This move came to light following a official document from December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "lopsided".
An official spokesperson has since clarified that the United States was demanding access to biological samples for scientific study and commercial gain while was unwilling to share the benefits from any future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for more dialogue to secure a deal suitable to both sides so the nation's critical HIV programme can continue.
Wider Context
This rejection comes after a comparable situation in Kenya, where a court suspended a related health funding agreement after concerns were raised about the security of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had administered assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and accountability.
Based on statements, 16 nations in Africa have so far signed similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Put simply, our country would provide the raw materials for medical research with no certainty that the end products would be accessible to our people should a new pandemic emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending structures previously set up through the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage future global health emergencies.
"This mechanism is intended to guarantee that when a nation provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to ongoing discussions with our US partners on how subsequent collaboration could be arranged in a manner that honours the sovereignty and dignity of both nations."
Medical Community Reaction
Medical experts stated it acknowledged the government's concerns, but urged that talks should continue since much of the nation's HIV programmes relied on external financing.
"Where specific concerns arise, including those involving data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," the group added.
This impasse highlights the complex debate between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.